<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-20971" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>Electroconvulsive Therapy</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Salik</surname>
            <given-names>Irim</given-names>
          </name>
          <aff>Westchester MC/New York Med. College</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Marwaha</surname>
            <given-names>Raman</given-names>
          </name>
          <aff>Case Western Reserve Un/MetroHealth MC</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Irim Salik declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Raman Marwaha declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>19</day>
          <month>9</month>
          <year>2022</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-20971.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>In a patient under intravenous sedation or general anesthesia, electroconvulsive therapy (ECT) uses an electric current to create a generalized cerebral seizure. Although it is primarily utilized to treat patients with severe depression, patients with schizophrenia, schizoaffective disorder, catatonia, neuroleptic malignant syndrome, and bipolar disorder may also benefit. This activity describes the indications, contraindications, and complications of ECT and highlights the role of the interprofessional team in the management of patients with mental health disorders.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Determine&#x000a0;the effects of electroconvulsive therapy.</p></list-item><list-item><p>Identify the potential uses of electroconvulsive therapy.</p></list-item><list-item><p>Assess&#x000a0;misinformation associated with electroconvulsive therapy.</p></list-item><list-item><p>Communicate&#x000a0;electroconvulsive therapy, and review the role of the interprofessional team in managing patients who undergo ECT.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20971&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20971">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-20971.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>In a patient under intravenous sedation or general anesthesia, electroconvulsive therapy (ECT) uses an electric current to create a generalized cerebral seizure. Although it is primarily utilized to treat patients with severe depression, patients with schizophrenia, schizoaffective disorder, catatonia, neuroleptic malignant syndrome, and bipolar disorder may also benefit. However, the practice has a stigma attached to it due to misinformation regarding procedural methodology.&#x000a0;</p>
      </sec>
      <sec id="article-20971.s3" sec-type="Anatomy and Physiology">
        <title>Anatomy and Physiology</title>
        <p>There are various pathophysiologic changes in brain regions found in patients with severe depression. These include reduced activity and volumetric reductions in the dorsal areas of the frontal lobes. Areas of the ventral and orbital frontal cortex have altered the processing of emotional stimuli.<xref ref-type="bibr" rid="article-20971.r1">[1]</xref>&#x000a0;In addition to the frontal lobe, functional alterations and volumetric reductions are apparent in the hippocampus, parahippocampal gyri, and amygdala.<xref ref-type="bibr" rid="article-20971.r2">[2]</xref>&#x000a0;The hypothalamic-pituitary-adrenal (HPA) axis becomes hypersensitive to stressors and exhibits chronically elevated levels of stress hormones and impaired feedback regulation.<xref ref-type="bibr" rid="article-20971.r3">[3]</xref> The mesocorticolimbic dopamine system, as well as the HPA axis, are activated in patients with stress. Dopamine function is thought to be impaired in patients with depression, causing impairment in essential functions, including concentration, motivation, and pleasure.<xref ref-type="bibr" rid="article-20971.r4">[4]</xref> The anti-depressive effects of ECT reflect changes in the systems mentioned above.</p>
      </sec>
      <sec id="article-20971.s4" sec-type="Indications">
        <title>Indications</title>
        <p>ECT is indicated in patients with treatment-resistant depression or severe major depression that impairs activities of daily living. The definition of treatment-resistant depression is depression that is unresponsive to multiple antidepressant medication trials.<xref ref-type="bibr" rid="article-20971.r5">[5]</xref> There are also suggestions for ECT as a treatment for suicidality, severe psychosis, food refusal secondary to depression, and catatonia.<xref ref-type="bibr" rid="article-20971.r6">[6]</xref><xref ref-type="bibr" rid="article-20971.r7">[7]</xref>&#x000a0;Bipolar depressive and manic patients can also receive treatment with ECT.<xref ref-type="bibr" rid="article-20971.r8">[8]</xref>&#x000a0;ECT may have a safer profile than antidepressants or antipsychotics in debilitated, elderly, pregnant, and breastfeeding patients. Suicidal ideation is rapidly relieved by ECT, and the complete resolution was seen in 38% of patients after&#x000a0;1 week, 61% of patients after 2 weeks, and 81% of patients with the completion of ECT.<xref ref-type="bibr" rid="article-20971.r9">[9]</xref>&#x000a0;ECT is also recommended for patients who have responded favorably to ECT.&#x000a0;</p>
      </sec>
      <sec id="article-20971.s5" sec-type="Contraindications">
        <title>Contraindications</title>
        <p>The resultant seizure from ECT can cause transient increases in blood pressure, myocardial oxygen consumption, heart rate, and intracranial pressure. Care is necessary for cardiovascular, pulmonary, or central nervous system-compromised patients. A pheochromocytoma and elevated intracranial pressure with mass effect are absolute contraindications to ECT. Relative contraindications include elevated intracranial pressure without mass effect, cardiovascular conduction defects, high-risk pregnancies, and aortic and cerebral aneurysms.<xref ref-type="bibr" rid="article-20971.r10">[10]</xref></p>
      </sec>
      <sec id="article-20971.s6" sec-type="Equipment">
        <title>Equipment</title>
        <p>ECT treatment and recovery areas should include the standard American Society of Anesthesiologists (ASA) monitors. A stethoscope, blood pressure monitor, electrocardiography (EKG) monitor, pulse oximeter, suction apparatus, and an oxygen delivery system should be present. Anesthetic induction supplies, medication, and ventilatory and resuscitation equipment should be available. A nasal cannula or face mask to provide supplemental oxygen, bag valve mask, nerve stimulator to assess neuromuscular blockade, electromyograph (EMG), electroencephalography (EEG) leads, and multiple blood pressure cuffs should be available.</p>
      </sec>
      <sec id="article-20971.s7" sec-type="Personnel">
        <title>Personnel</title>
        <p>ECT is administered by a team that typically includes an anesthesiologist, a psychiatrist, and a nurse.&#x000a0;</p>
      </sec>
      <sec id="article-20971.s8" sec-type="Preparation">
        <title>Preparation</title>
        <p>A complete history and physical examination may expose significant risk factors, including cardiac ischemia or arrhythmia, heart failure, or intracranial pathology.<xref ref-type="bibr" rid="article-20971.r11">[11]</xref> History should also include the use of herbal medications such as Ginkgo biloba, ginseng, St John's wort, valerian, and kava, all of which may interfere with ECT. There is a risk of status epilepticus in patients on theophylline.<xref ref-type="bibr" rid="article-20971.r12">[12]</xref>&#x000a0;Short-acting intravenous beta-blockers may reduce ECT-related hypertension and tachycardia but may also shorten seizure duration and reduce ECT efficacy. Cardiac medications, including aspirin, statins, antihypertensive agents, antianginal medications, and clopidogrel, should be continued on the day of the procedure. Serum glucose levels require checking both preoperatively and in the recovery room, as ECT treatments can raise blood glucose levels. Although ECT appears safe in a patient with a defibrillator, detection mode should be turned off during the procedure, and equipment for external defibrillation should be available at the patient&#x02019;s bedside. In pregnant patients, noninvasive fetal monitoring is recommended after 14 to 16 weeks, and a nonstress test with a tocometer after 24 weeks.</p>
        <p>ECT utilizes general anesthesia. Anesthetic induction medications used include barbiturates such as thiopental and methohexital and nonbarbiturate agents such as propofol and etomidate. Seizure-induced by ECT should last longer than 30 seconds. Methohexital is the&#x000a0;most commonly used induction agent due to its quick onset, effectiveness, low cost, and minimal effect on seizure duration. Propofol and thiopental have been shown to reduce seizure duration. Etomidate has correlations with myoclonus and increased seizure duration.</p>
      </sec>
      <sec id="article-20971.s9" sec-type="Technique or Treatment">
        <title>Technique or Treatment</title>
        <p>ECT is commonly performed in a dedicated suite, a post-anesthesia care unit, or an ambulatory surgery site, most frequently on an outpatient basis. Patients with severe debilitation, including substantial medical or psychiatric illness, may start on an inpatient basis and transition to an outpatient basis as needed. Patients should be appropriately nil per os (NPO) for the procedure, which includes no light meal for&#x000a0;6 hours, no full-fat meal for&#x000a0;8 hours, and no clear liquids for&#x000a0;2 hours before anesthesia.</p>
        <p>Vital signs, including blood oxygen saturation, ECG, and EEG activity, are recorded continuously. EMG is recorded on the right foot to measure the motor component of seizure activity. A nerve stimulator monitors succinylcholine, a depolarizing muscle relaxant that reduces tonic-clonic contractions during the procedure. As an alternative to EMG, a blood pressure cuff is inflated on the patient&#x02019;s ankle to prevent succinylcholine from entering the foot, allowing a visual monitor of seizure activity with measurement of tonic-clonic contractions. Following intravenous induction, a bite block is placed to protect the patient&#x02019;s tongue and teeth. The beginning and termination of a cerebral seizure are monitored via EEG, recorded from right and left frontal and mastoid positions. Seizure induction is via&#x000a0;2 electrodes placed temporally or a right unilateral electrode, allowing electrical current to pass into the scalp.<xref ref-type="bibr" rid="article-20971.r13">[13]</xref>&#x000a0;A 2017 meta-analysis of numerous randomized trials of 792 patients specifically compared&#x000a0;moderate bilateral ECT with&#x000a0;high-dose&#x000a0;right unilateral ECT, and remission was comparable.<xref ref-type="bibr" rid="article-20971.r14">[14]</xref>&#x000a0;Right unilateral ECT is utilized preferentially to minimize retrograde amnesia.</p>
        <p>The ECT stimulus is either a brief pulse (0.5 to 2.0 milliseconds) or an ultra-brief pulse (less than 0.5 milliseconds) waveform. While the brief pulse is considered standard, the ultra-brief is more tolerable.<xref ref-type="bibr" rid="article-20971.r15">[15]</xref>&#x000a0;Electricity dose affects efficacy, the speed of response, and adverse cognitive effects. Seizure threshold is established via trial and error via incrementally higher current doses during the primary treatment session.<xref ref-type="bibr" rid="article-20971.r16">[16]</xref><xref ref-type="bibr" rid="article-20971.r17">[17]</xref>&#x000a0;Following initial dose calculation, the dose at subsequent ECT sessions for bilateral ECT is 1.5 to 2 times the seizure threshold, and for right unilateral is&#x000a0;6 times the seizure threshold. During ECT treatment, the seizure threshold commonly increases as the patient develops tolerance.</p>
        <p>As with any other procedure, the anesthesiologist's goal during ECT is to facilitate a safe and pain-free experience for the patient.<xref ref-type="bibr" rid="article-20971.r18">[18]</xref>&#x000a0;Preoxygenation of the patient via nasal cannula or face mask is followed by anesthetic induction and paralysis. Administration of an anticholinergic medication before ECT may prevent arrhythmias such as bradycardia or asystole and excessive oral secretions. To induce cerebral vasoconstriction via hypocarbia, the patient is often hyperventilated via a bag valve mask before delivery of the electrical stimulus to increase seizure intensity.<xref ref-type="bibr" rid="article-20971.r19">[19]</xref>The gold standard for induction of anesthesia is methohexital, given at 0.75 to 1&#x000a0;mg/kg.<xref ref-type="bibr" rid="article-20971.r18">[18]</xref>&#x000a0;Methohexital is preferred to propofol because a meta-analysis of&#x000a0;2 randomized trials revealed that seizure duration was shorter with propofol.<xref ref-type="bibr" rid="article-20971.r20">[20]</xref>&#x000a0;Skeletal muscle relaxation during ECT is integral to minimizing a motor seizure and avoiding musculoskeletal injury. The depolarizing neuromuscular relaxant succinylcholine is used at 0.75 to 1&#x000a0;mg/kg with an elimination half-life of 41 seconds.<xref ref-type="bibr" rid="article-20971.r21">[21]</xref><xref ref-type="bibr" rid="article-20971.r22">[22]</xref>&#x000a0; In cases where succinylcholine is contraindicated, including neuromuscular disease or injury, burn injury, pseudocholinesterase deficiency, or hyperkalemia, nondepolarizing neuromuscular relaxants are preferred.<xref ref-type="bibr" rid="article-20971.r5">[5]</xref></p>
        <p>Once the patient is rendered unconscious, administration of a muscle relaxant follows, along with bag valve mask ventilation with 100 percent oxygen. A nerve stimulator is utilized to determine the adequacy of muscle relaxation and the clinical assessment of plantar reflexes and fasciculations in the calves and left foot. An inflated blood pressure cuff prevents muscle relaxants from entering the right foot. Muscle relaxants do not prevent masseter muscle contraction from the electrical pulse, requiring placement of a bite block for lingual and tooth protection.</p>
        <p>Although most therapeutic ECT seizures last 15 to 70 seconds, EEG recording lasts about 25 percent longer than motor seizures.<xref ref-type="bibr" rid="article-20971.r23">[23]</xref>&#x000a0;Seizures lasting less than 15 seconds may not be clinically effective, while prolonged seizures may cause cognitive impairment. A missed or short seizure should have a follow-up with a short period of hyperventilation and restimulation with a higher electrical current. If a patient is experiencing a prolonged seizure greater than&#x000a0;2 minutes, an induction agent, such as propofol or methohexital, is either given at a half dose or a benzodiazepine to suppress seizure activity and avoid neurologic injury. In a patient with numerous missed seizures,&#x000a0;anesthetic induction agents such as etomidate or ketamine may be useful as they exhibit fewer anticonvulsant effects as compared to methohexital. While caffeine had been previously administered to prolong seizures, it is no longer recommended due to its uncertain safety profile for this purpose.<xref ref-type="bibr" rid="article-20971.r24">[24]</xref><xref ref-type="bibr" rid="article-20971.r12">[12]</xref></p>
        <p>In pregnant patients receiving ECT,&#x000a0;hyperventilation should be avoided as it can reduce placental blood flow, causing fetal hypoxia. Minimization of NPO time and adequate intravenous fluid hydration is essential to avoid dehydration and premature uterine contractions. Left lateral uterine displacement is essential in a female with a gestational age greater than 20 weeks to optimize maternal venous return and maintain optimal uterine blood flow. In pregnancies, greater than 24 weeks gestation considered viable, fetal heart rate and uterine activity should undergo continuous monitoring 30 minutes before and after each treatment by an obstetrician who can manage obstetric and neonatal emergencies. Because pregnant patients are at higher risk for aspiration pneumonitis due to their full stomach status, anticholinergic drugs that reduce lower esophageal sphincter tone should be avoided, as they can increase reflux.<xref ref-type="bibr" rid="article-20971.r25">[25]</xref><xref ref-type="bibr" rid="article-20971.r26">[26]</xref><xref ref-type="bibr" rid="article-20971.r27">[27]</xref><xref ref-type="bibr" rid="article-20971.r28">[28]</xref> &#x000a0;In this case, a nonparticulate antacid such as sodium citrate is safer for aspiration prophylaxis.</p>
      </sec>
      <sec id="article-20971.s10" sec-type="Complications">
        <title>Complications</title>
        <p>Bilateral or bitemporal ECT causes more cognitive impairment than unilateral ECT, although this effect is transient. A meta-analysis of 1415 depressed patients treated with ECT revealed that global cognition, verbal memory, and autobiographical memory were worse with bilateral treatment&#x000a0;3 days after treatment.<xref ref-type="bibr" rid="article-20971.r29">[29]</xref></p>
        <p>According to the American Psychiatric Association, patients receiving ECT are at higher risk if they show evidence of unstable or severe cardiovascular disease, a space-occupying intracranial lesion with evidence of elevated intracranial pressure, a history of an acute cerebral hemorrhage or stroke, an unstable vascular aneurysm, severe pulmonary disease, or qualify as American Society of Anesthesiologists (ASA) Class 4 or 5.</p>
        <p>Physiologically, during the tonic phase of the seizure, a 15- to 20-second parasympathetic discharge occurs, which can lead to bradyarrhythmias, including premature atrial and ventricular contractions, atrioventricular block, and asystole. Patients with subconvulsive seizures are at higher risk for asystole.<xref ref-type="bibr" rid="article-20971.r30">[30]</xref>&#x000a0;Paradoxically, patients with heart block&#x000a0;or underlying arrhythmias are less likely to develop asystole. The clonic phase of the seizure correlates with a catecholamine surge that causes tachycardia and hypertension, which lasts temporally with seizure duration.<xref ref-type="bibr" rid="article-20971.r31">[31]</xref>&#x000a0;Hypertension and tachycardia resolve within 10 to 20 minutes of the seizure, although some patients exhibit persistent hypertension that requires medical intervention.</p>
        <p>Although patients with cardiac disease at baseline are at higher risk following treatment, ejection fraction can also decrease following ECT in healthy patients.<xref ref-type="bibr" rid="article-20971.r32">[32]</xref>&#x000a0;In a study of 53 adults undergoing ECT,&#x000a0;7 developed new global left ventricular (LV) systolic dysfunction, and&#x000a0;8 developed regional wall motion abnormalities.<xref ref-type="bibr" rid="article-20971.r33">[33]</xref>&#x000a0;Of these patients, no adverse outcomes were in patients with LV dysfunction. In a prospective cohort study of 100 subjects undergoing ECT, increased cardiac troponin levels were present in&#x000a0;8 patients, with only&#x000a0;2 having other evidence of myocardial ischemia or infarction.<xref ref-type="bibr" rid="article-20971.r34">[34]</xref>&#x000a0;Cerebral blood flow and intracranial pressure both increase with ECT therapy. Clinically, patients may exhibit confusion, delirium, disorientation, and memory loss. ECT is classified as a low-risk procedure by the AHA-ACC guidelines because it is well tolerated, and demonstrates only transient hemodynamic lability and low mortality rate.<xref ref-type="bibr" rid="article-20971.r35">[35]</xref><xref ref-type="bibr" rid="article-20971.r36">[36]</xref><xref ref-type="bibr" rid="article-20971.r37">[37]</xref></p>
      </sec>
      <sec id="article-20971.s11" sec-type="Clinical Significance">
        <title>Clinical Significance</title>
        <p>ECT is a relatively safe and low-risk procedure that is helpful in&#x000a0;the treatment of depression, suicidality, severe psychosis, food refusal secondary to depression, and catatonia. It requires interprofessional care coordination among anesthesiologists, psychiatrists, and nurses. Most patients require several sessions to see a durable effect. The stigma associated with ECT is largely due to the lack of anesthesia with early treatments, resulting in significant injury and severe memory loss. The antidepressant effect is seen relatively quickly and may last up to a few years. Overall, the mortality rate is very low with ECT administered in a controlled setting, but it continues to cause mild memory loss in the long term. ECT is commonly utilized in pregnant patients and the elderly due to the avoidance of psychotropic medication side effects. Although its mechanism of action is multifactorial, ECT causes changes in cerebral blood flow and regional metabolism.&#x000a0;</p>
      </sec>
      <sec id="article-20971.s12" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>Today, ECT is now frequently used to treat a variety of mental health disorders besides depression. The procedure is relatively safe and does work. However, the delivery of ECT requires an interprofessional team that includes a nurse, anesthesiologist, psychiatrist, and a neurologist. The benefits of ECT are seen after several sessions, and the results are durable. The key is to educate the patient and family about ECT because the procedure has been associated with many false and illogical beliefs. The antidepressant effect is seen relatively quickly and may last up to a few years. Overall, the mortality rate is very low with ECT administered in a controlled setting, but it continues to cause mild memory loss in the long term. ECT is commonly utilized in pregnant patients and the elderly due to the avoidance of psychotropic medication side effects. Although its mechanism of action is multifactorial, ECT causes changes in cerebral blood flow and regional metabolism. Most patients who undergo ECT have a beneficial response without any adverse sequelae.<xref ref-type="bibr" rid="article-20971.r38">[38]</xref></p>
      </sec>
      <sec id="article-20971.s13">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=20971&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=20971">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/20971/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=20971">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <ref-list id="article-20971.s14">
        <title>References</title>
        <ref id="article-20971.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mayberg</surname>
                <given-names>HS</given-names>
              </name>
              <name>
                <surname>Lewis</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Regenold</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Wagner</surname>
                <given-names>HN</given-names>
              </name>
            </person-group>
            <article-title>Paralimbic hypoperfusion in unipolar depression.</article-title>
            <source>J Nucl Med</source>
            <year>1994</year>
            <month>Jun</month>
            <volume>35</volume>
            <issue>6</issue>
            <fpage>929</fpage>
            <page-range>929-34</page-range>
            <pub-id pub-id-type="pmid">8195877</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r2">
          <label>2</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Botteron</surname>
                <given-names>KN</given-names>
              </name>
              <name>
                <surname>Raichle</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Drevets</surname>
                <given-names>WC</given-names>
              </name>
              <name>
                <surname>Heath</surname>
                <given-names>AC</given-names>
              </name>
              <name>
                <surname>Todd</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>Volumetric reduction in left subgenual prefrontal cortex in early onset depression.</article-title>
            <source>Biol Psychiatry</source>
            <year>2002</year>
            <month>Feb</month>
            <day>15</day>
            <volume>51</volume>
            <issue>4</issue>
            <fpage>342</fpage>
            <page-range>342-4</page-range>
            <pub-id pub-id-type="pmid">11958786</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>de Kwaasteniet</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Ruhe</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Caan</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rive</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Olabarriaga</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Groefsema</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Heesink</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>van Wingen</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Denys</surname>
                <given-names>D</given-names>
              </name>
            </person-group>
            <article-title>Relation between structural and functional connectivity in major depressive disorder.</article-title>
            <source>Biol Psychiatry</source>
            <year>2013</year>
            <month>Jul</month>
            <day>01</day>
            <volume>74</volume>
            <issue>1</issue>
            <fpage>40</fpage>
            <page-range>40-7</page-range>
            <pub-id pub-id-type="pmid">23399372</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rigucci</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Serafini</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Pompili</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Kotzalidis</surname>
                <given-names>GD</given-names>
              </name>
              <name>
                <surname>Tatarelli</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Anatomical and functional correlates in major depressive disorder: the contribution of neuroimaging studies.</article-title>
            <source>World J Biol Psychiatry</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>11</volume>
            <issue>2 Pt 2</issue>
            <fpage>165</fpage>
            <page-range>165-80</page-range>
            <pub-id pub-id-type="pmid">19670087</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <collab>American Psychiatric Association. Task Force on Electroconvulsive Therapy</collab>
            <article-title>The Practice of ECT: Recommendations for Treatment, Training and Privileging.</article-title>
            <source>Convuls Ther</source>
            <year>1990</year>
            <month>Jun</month>
            <volume>6</volume>
            <issue>2</issue>
            <fpage>85</fpage>
            <page-range>85-120</page-range>
            <pub-id pub-id-type="pmid">11659302</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Husain</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Rush</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Knapp</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Petrides</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rummans</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Biggs</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Litle</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Zhao</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Bernstein</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McClintock</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Bailine</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Kellner</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Speed of response and remission in major depressive disorder with acute electroconvulsive therapy (ECT): a Consortium for Research in ECT (CORE) report.</article-title>
            <source>J Clin Psychiatry</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>65</volume>
            <issue>4</issue>
            <fpage>485</fpage>
            <page-range>485-91</page-range>
            <pub-id pub-id-type="pmid">15119910</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kellner</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Knapp</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Husain</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Sampson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Cullum</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McClintock</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Tobias</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Martino</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bailine</surname>
                <given-names>SH</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Petrides</surname>
                <given-names>G</given-names>
              </name>
            </person-group>
            <article-title>Bifrontal, bitemporal and right unilateral electrode placement in ECT: randomised trial.</article-title>
            <source>Br J Psychiatry</source>
            <year>2010</year>
            <month>Mar</month>
            <volume>196</volume>
            <issue>3</issue>
            <fpage>226</fpage>
            <page-range>226-34</page-range>
            <pub-id pub-id-type="pmid">20194546</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fink</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Indications for the use of ECT.</article-title>
            <source>Psychopharmacol Bull</source>
            <year>1994</year>
            <volume>30</volume>
            <issue>3</issue>
            <fpage>269</fpage>
            <page-range>269-75; discussion 276-80</page-range>
            <pub-id pub-id-type="pmid">7878176</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kellner</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Knapp</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Petrides</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Husain</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rummans</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Bernstein</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Rasmussen</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>O'connor</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Rush</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Biggs</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>McClintock</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bailine</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Malur</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>Relief of expressed suicidal intent by ECT: a consortium for research in ECT study.</article-title>
            <source>Am J Psychiatry</source>
            <year>2005</year>
            <month>May</month>
            <volume>162</volume>
            <issue>5</issue>
            <fpage>977</fpage>
            <page-range>977-82</page-range>
            <pub-id pub-id-type="pmid">15863801</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Taylor</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Electroconvulsive therapy: a review of history, patient selection, technique, and medication management.</article-title>
            <source>South Med J</source>
            <year>2007</year>
            <month>May</month>
            <volume>100</volume>
            <issue>5</issue>
            <fpage>494</fpage>
            <page-range>494-8</page-range>
            <pub-id pub-id-type="pmid">17534086</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Tess</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Smetana</surname>
                <given-names>GW</given-names>
              </name>
            </person-group>
            <article-title>Medical evaluation of patients undergoing electroconvulsive therapy.</article-title>
            <source>N Engl J Med</source>
            <year>2009</year>
            <month>Apr</month>
            <day>02</day>
            <volume>360</volume>
            <issue>14</issue>
            <fpage>1437</fpage>
            <page-range>1437-44</page-range>
            <pub-id pub-id-type="pmid">19339723</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Devanand</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Decina</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Sackeim</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Prudic</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Status epilepticus following ECT in a patient receiving theophylline.</article-title>
            <source>J Clin Psychopharmacol</source>
            <year>1988</year>
            <month>Apr</month>
            <volume>8</volume>
            <issue>2</issue>
            <fpage>153</fpage>
            <pub-id pub-id-type="pmid">3372714</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bj&#x000f8;lseth</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Engedal</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Benth</surname>
                <given-names>J&#x00160;</given-names>
              </name>
              <name>
                <surname>Dybedal</surname>
                <given-names>GS</given-names>
              </name>
              <name>
                <surname>Gaarden</surname>
                <given-names>TL</given-names>
              </name>
              <name>
                <surname>Tanum</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Clinical efficacy of formula-based bifrontal versus right unilateral electroconvulsive therapy (ECT) in the treatment of major depression among elderly patients: a pragmatic, randomized, assessor-blinded, controlled trial.</article-title>
            <source>J Affect Disord</source>
            <year>2015</year>
            <month>Apr</month>
            <day>01</day>
            <volume>175</volume>
            <fpage>8</fpage>
            <page-range>8-17</page-range>
            <pub-id pub-id-type="pmid">25590761</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kolshus</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Jelovac</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McLoughlin</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Bitemporal v. high-dose right unilateral electroconvulsive therapy for depression: a systematic review and meta-analysis of randomized controlled trials.</article-title>
            <source>Psychol Med</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>47</volume>
            <issue>3</issue>
            <fpage>518</fpage>
            <page-range>518-530</page-range>
            <pub-id pub-id-type="pmid">27780482</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sienaert</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Spaans</surname>
                <given-names>HP</given-names>
              </name>
              <name>
                <surname>Kellner</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Pulse Width in Electroconvulsive Therapy: How Brief Is Brief?</article-title>
            <source>J ECT</source>
            <year>2018</year>
            <month>Jun</month>
            <volume>34</volume>
            <issue>2</issue>
            <fpage>73</fpage>
            <page-range>73-74</page-range>
            <pub-id pub-id-type="pmid">29489561</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petrides</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>The "half-age" stimulation strategy for ECT dosing.</article-title>
            <source>Convuls Ther</source>
            <year>1996</year>
            <month>Sep</month>
            <volume>12</volume>
            <issue>3</issue>
            <fpage>138</fpage>
            <page-range>138-46</page-range>
            <pub-id pub-id-type="pmid">8872401</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Petrides</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Braga</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Fink</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mueller</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Knapp</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Husain</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Rummans</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bailine</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Malur</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>O'Connor</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Kellner</surname>
                <given-names>C</given-names>
              </name>
              <collab>CORE (Consortium for Research in ECT) Group</collab>
            </person-group>
            <article-title>Seizure threshold in a large sample: implications for stimulus dosing strategies in bilateral electroconvulsive therapy: a report from CORE.</article-title>
            <source>J ECT</source>
            <year>2009</year>
            <month>Dec</month>
            <volume>25</volume>
            <issue>4</issue>
            <fpage>232</fpage>
            <page-range>232-7</page-range>
            <pub-id pub-id-type="pmid">19972637</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bryson</surname>
                <given-names>EO</given-names>
              </name>
              <name>
                <surname>Aloysi</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Farber</surname>
                <given-names>KG</given-names>
              </name>
              <name>
                <surname>Kellner</surname>
                <given-names>CH</given-names>
              </name>
            </person-group>
            <article-title>Individualized Anesthetic Management for Patients Undergoing Electroconvulsive Therapy: A Review of Current Practice.</article-title>
            <source>Anesth Analg</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>124</volume>
            <issue>6</issue>
            <fpage>1943</fpage>
            <page-range>1943-1956</page-range>
            <pub-id pub-id-type="pmid">28277323</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bergsholm</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Gran</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Bleie</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Seizure duration in unilateral electroconvulsive therapy. The effect of hypocapnia induced by hyperventilation and the effect of ventilation with oxygen.</article-title>
            <source>Acta Psychiatr Scand</source>
            <year>1984</year>
            <month>Feb</month>
            <volume>69</volume>
            <issue>2</issue>
            <fpage>121</fpage>
            <page-range>121-8</page-range>
            <pub-id pub-id-type="pmid">6422704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lihua</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Su</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ke</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Ziemann-Gimmel</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Different regimens of intravenous sedatives or hypnotics for electroconvulsive therapy (ECT) in adult patients with depression.</article-title>
            <source>Cochrane Database Syst Rev</source>
            <year>2014</year>
            <month>Apr</month>
            <day>11</day>
            <volume>2014</volume>
            <issue>4</issue>
            <fpage>CD009763</fpage>
            <pub-id pub-id-type="pmid">24723301</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bryson</surname>
                <given-names>EO</given-names>
              </name>
              <name>
                <surname>Kellner</surname>
                <given-names>CH</given-names>
              </name>
              <name>
                <surname>Li</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Aloysi</surname>
                <given-names>AS</given-names>
              </name>
              <name>
                <surname>Majeske</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Extreme variability in succinylcholine dose for muscle relaxation in electroconvulsive therapy.</article-title>
            <source>Australas Psychiatry</source>
            <year>2018</year>
            <month>Aug</month>
            <volume>26</volume>
            <issue>4</issue>
            <fpage>391</fpage>
            <page-range>391-393</page-range>
            <pub-id pub-id-type="pmid">29504412</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Torda</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Graham</surname>
                <given-names>GG</given-names>
              </name>
              <name>
                <surname>Warwick</surname>
                <given-names>NR</given-names>
              </name>
              <name>
                <surname>Donohue</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Pharmacokinetics and pharmacodynamics of suxamethonium.</article-title>
            <source>Anaesth Intensive Care</source>
            <year>1997</year>
            <month>Jun</month>
            <volume>25</volume>
            <issue>3</issue>
            <fpage>272</fpage>
            <page-range>272-8</page-range>
            <pub-id pub-id-type="pmid">9209610</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mayur</surname>
                <given-names>PM</given-names>
              </name>
              <name>
                <surname>Gangadhar</surname>
                <given-names>BN</given-names>
              </name>
              <name>
                <surname>Janakiramaiah</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Subbakrishna</surname>
                <given-names>DK</given-names>
              </name>
            </person-group>
            <article-title>Motor seizure monitoring during electroconvulsive therapy.</article-title>
            <source>Br J Psychiatry</source>
            <year>1999</year>
            <month>Mar</month>
            <volume>174</volume>
            <fpage>270</fpage>
            <page-range>270-2</page-range>
            <pub-id pub-id-type="pmid">10448455</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Datto</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Rai</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Ilivicky</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Caroff</surname>
                <given-names>SN</given-names>
              </name>
            </person-group>
            <article-title>Augmentation of seizure induction in electroconvulsive therapy: a clinical reappraisal.</article-title>
            <source>J ECT</source>
            <year>2002</year>
            <month>Sep</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>118</fpage>
            <page-range>118-25</page-range>
            <pub-id pub-id-type="pmid">12394529</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Miller</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Use of electroconvulsive therapy during pregnancy.</article-title>
            <source>Hosp Community Psychiatry</source>
            <year>1994</year>
            <month>May</month>
            <volume>45</volume>
            <issue>5</issue>
            <fpage>444</fpage>
            <page-range>444-50</page-range>
            <pub-id pub-id-type="pmid">8045538</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rabheru</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>The use of electroconvulsive therapy in special patient populations.</article-title>
            <source>Can J Psychiatry</source>
            <year>2001</year>
            <month>Oct</month>
            <volume>46</volume>
            <issue>8</issue>
            <fpage>710</fpage>
            <page-range>710-9</page-range>
            <pub-id pub-id-type="pmid">11692973</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Yonkers</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Wisner</surname>
                <given-names>KL</given-names>
              </name>
              <name>
                <surname>Stowe</surname>
                <given-names>Z</given-names>
              </name>
              <name>
                <surname>Leibenluft</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Cohen</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Manber</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Viguera</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Suppes</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Altshuler</surname>
                <given-names>L</given-names>
              </name>
            </person-group>
            <article-title>Management of bipolar disorder during pregnancy and the postpartum period.</article-title>
            <source>Am J Psychiatry</source>
            <year>2004</year>
            <month>Apr</month>
            <volume>161</volume>
            <issue>4</issue>
            <fpage>608</fpage>
            <page-range>608-20</page-range>
            <pub-id pub-id-type="pmid">15056503</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Anderson</surname>
                <given-names>EL</given-names>
              </name>
              <name>
                <surname>Reti</surname>
                <given-names>IM</given-names>
              </name>
            </person-group>
            <article-title>ECT in pregnancy: a review of the literature from 1941 to 2007.</article-title>
            <source>Psychosom Med</source>
            <year>2009</year>
            <month>Feb</month>
            <volume>71</volume>
            <issue>2</issue>
            <fpage>235</fpage>
            <page-range>235-42</page-range>
            <pub-id pub-id-type="pmid">19073751</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Semkovska</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Keane</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Babalola</surname>
                <given-names>O</given-names>
              </name>
              <name>
                <surname>McLoughlin</surname>
                <given-names>DM</given-names>
              </name>
            </person-group>
            <article-title>Unilateral brief-pulse electroconvulsive therapy and cognition: effects of electrode placement, stimulus dosage and time.</article-title>
            <source>J Psychiatr Res</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>45</volume>
            <issue>6</issue>
            <fpage>770</fpage>
            <page-range>770-80</page-range>
            <pub-id pub-id-type="pmid">21109254</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kaufman</surname>
                <given-names>KR</given-names>
              </name>
            </person-group>
            <article-title>Asystole with electroconvulsive therapy.</article-title>
            <source>J Intern Med</source>
            <year>1994</year>
            <month>Mar</month>
            <volume>235</volume>
            <issue>3</issue>
            <fpage>275</fpage>
            <page-range>275-7</page-range>
            <pub-id pub-id-type="pmid">8120525</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Larson</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Swartz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Abrams</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>Duration of ECT-induced tachycardia as a measure of seizure length.</article-title>
            <source>Am J Psychiatry</source>
            <year>1984</year>
            <month>Oct</month>
            <volume>141</volume>
            <issue>10</issue>
            <fpage>1269</fpage>
            <page-range>1269-71</page-range>
            <pub-id pub-id-type="pmid">6486265</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fuenmayor</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>el Fakih</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Moreno</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Fuenmayor</surname>
                <given-names>AM</given-names>
              </name>
            </person-group>
            <article-title>Effects of electroconvulsive therapy on cardiac function in patients without heart disease.</article-title>
            <source>Cardiology</source>
            <year>1997</year>
            <season>May-Jun</season>
            <volume>88</volume>
            <issue>3</issue>
            <fpage>254</fpage>
            <page-range>254-7</page-range>
            <pub-id pub-id-type="pmid">9129846</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>McCully</surname>
                <given-names>RB</given-names>
              </name>
              <name>
                <surname>Karon</surname>
                <given-names>BL</given-names>
              </name>
              <name>
                <surname>Rummans</surname>
                <given-names>TA</given-names>
              </name>
              <name>
                <surname>Black</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Andreen</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Oh</surname>
                <given-names>JK</given-names>
              </name>
              <name>
                <surname>Seward</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Tajik</surname>
                <given-names>AJ</given-names>
              </name>
            </person-group>
            <article-title>Frequency of left ventricular dysfunction after electroconvulsive therapy.</article-title>
            <source>Am J Cardiol</source>
            <year>2003</year>
            <month>May</month>
            <day>01</day>
            <volume>91</volume>
            <issue>9</issue>
            <fpage>1147</fpage>
            <page-range>1147-50</page-range>
            <pub-id pub-id-type="pmid">12714169</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Duma</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pal</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Johnston</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Helwani</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Bhat</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gill</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Rosenkvist</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Cartmill</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Brown</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Miller</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Scott</surname>
                <given-names>MG</given-names>
              </name>
              <name>
                <surname>Sanchez-Conde</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Jarvis</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Farber</surname>
                <given-names>NB</given-names>
              </name>
              <name>
                <surname>Zorumski</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Conway</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Nagele</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>High-sensitivity Cardiac Troponin Elevation after Electroconvulsive Therapy: A Prospective, Observational Cohort Study.</article-title>
            <source>Anesthesiology</source>
            <year>2017</year>
            <month>Apr</month>
            <volume>126</volume>
            <issue>4</issue>
            <fpage>643</fpage>
            <page-range>643-652</page-range>
            <pub-id pub-id-type="pmid">28166110</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zielinski</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Roose</surname>
                <given-names>SP</given-names>
              </name>
              <name>
                <surname>Devanand</surname>
                <given-names>DP</given-names>
              </name>
              <name>
                <surname>Woodring</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sackeim</surname>
                <given-names>HA</given-names>
              </name>
            </person-group>
            <article-title>Cardiovascular complications of ECT in depressed patients with cardiac disease.</article-title>
            <source>Am J Psychiatry</source>
            <year>1993</year>
            <month>Jun</month>
            <volume>150</volume>
            <issue>6</issue>
            <fpage>904</fpage>
            <page-range>904-9</page-range>
            <pub-id pub-id-type="pmid">8494067</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Rice</surname>
                <given-names>EH</given-names>
              </name>
              <name>
                <surname>Sombrotto</surname>
                <given-names>LB</given-names>
              </name>
              <name>
                <surname>Markowitz</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Leon</surname>
                <given-names>AC</given-names>
              </name>
            </person-group>
            <article-title>Cardiovascular morbidity in high-risk patients during ECT.</article-title>
            <source>Am J Psychiatry</source>
            <year>1994</year>
            <month>Nov</month>
            <volume>151</volume>
            <issue>11</issue>
            <fpage>1637</fpage>
            <page-range>1637-41</page-range>
            <pub-id pub-id-type="pmid">7943453</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Abrams</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The mortality rate with ECT.</article-title>
            <source>Convuls Ther</source>
            <year>1997</year>
            <month>Sep</month>
            <volume>13</volume>
            <issue>3</issue>
            <fpage>125</fpage>
            <page-range>125-7</page-range>
            <pub-id pub-id-type="pmid">9342128</pub-id>
          </element-citation>
        </ref>
        <ref id="article-20971.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Benson</surname>
                <given-names>NM</given-names>
              </name>
              <name>
                <surname>Seiner</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Bolton</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Fitzmaurice</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Meisner</surname>
                <given-names>RC</given-names>
              </name>
              <name>
                <surname>Pierce</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Busch</surname>
                <given-names>AB</given-names>
              </name>
            </person-group>
            <article-title>Acute Phase Treatment Outcomes of Electroconvulsive Therapy in Adolescents and Young Adults.</article-title>
            <source>J ECT</source>
            <year>2019</year>
            <month>Sep</month>
            <volume>35</volume>
            <issue>3</issue>
            <fpage>178</fpage>
            <page-range>178-183</page-range>
            <pub-id pub-id-type="pmid">30562200</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
